Molecular and neural roles of sodium-glucose cotransporter 2 inhibitors in alleviating neurocognitive impairment in diabetic mice

Diabetes causes a variety of molecular changes in the brain, making it a real risk factor for the development of cognitive dysfunction. Complex pathogenesis and clinical heterogeneity of cognitive impairment makes the efficacy of current drugs limited. Sodium-glucose cotransporter 2 inhibitors (SGLT...

Descripción completa

Detalles Bibliográficos
Autores principales: Piątkowska-Chmiel, Iwona, Herbet, Mariola, Gawrońska-Grzywacz, Monika, Pawłowski, Kamil, Ostrowska-Leśko, Marta, Dudka, Jarosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006050/
https://www.ncbi.nlm.nih.gov/pubmed/36869919
http://dx.doi.org/10.1007/s00213-023-06341-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006050/
https://www.ncbi.nlm.nih.gov/pubmed/36869919
http://dx.doi.org/10.1007/s00213-023-06341-7

Ejemplares similares